Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial
- 8 October 2004
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 364 (9441), 1229-1235
- https://doi.org/10.1016/s0140-6736(04)17139-0
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661Antiviral Research, 2011
- Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human HepatocytesDrug Metabolism and Disposition, 2010
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977Published by Elsevier BV ,2010
- Recent advances in structure and function of cytosolic IMP-GMP specific 5′nucleotidase II (cN-II)Purinergic Signalling, 2006
- THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Liver-Targeted Drug Delivery Using HepDirect ProdrugsJournal of Pharmacology and Experimental Therapeutics, 2004
- Antiviral drugs in current clinical useJournal of Clinical Virology, 2004
- Design, Synthesis, and Characterization of a Series of Cytochrome P450 3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver§Journal of the American Chemical Society, 2004
- Ecto‐enzyme and signaling functions of lymphocyte CD 7 3Immunological Reviews, 1998
- How to establish equivalence between treatments: A one‐sided clinical trial in paediatric oncologyStatistics in Medicine, 1989